These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32305450)

  • 1. Myofibers deficient in connexins 43 and 45 expression protect mice from skeletal muscle and systemic dysfunction promoted by a dysferlin mutation.
    Fernández G; Arias-Bravo G; Bevilacqua JA; Castillo-Ruiz M; Caviedes P; Sáez JC; Cea LA
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165800. PubMed ID: 32305450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of Hemichannels Normalizes the Differentiation Fate of Myoblasts and Features of Skeletal Muscles from Dysferlin-Deficient Mice.
    Cea LA; Fernández G; Arias-Bravo G; Castillo-Ruiz M; Escamilla R; Brañes MC; Sáez JC
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes.
    Cea LA; Bevilacqua JA; Arriagada C; Cárdenas AM; Bigot A; Mouly V; Sáez JC; Caviedes P
    BMC Cell Biol; 2016 May; 17 Suppl 1(Suppl 1):15. PubMed ID: 27229680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone-induced muscular atrophy is mediated by functional expression of connexin-based hemichannels.
    Cea LA; Balboa E; Puebla C; Vargas AA; Cisterna BA; Escamilla R; Regueira T; Sáez JC
    Biochim Biophys Acta; 2016 Oct; 1862(10):1891-9. PubMed ID: 27437607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo expression of functional connexins 43 and 45 hemichannels increases sarcolemmal permeability of skeletal myofibers during endotoxemia.
    Cea LA; Balboa E; Vargas AA; Puebla C; Brañes MC; Escamilla R; Regueira T; Sáez JC
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2765-2773. PubMed ID: 31228617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice.
    Lloyd EM; Xu H; Murphy RM; Grounds MD; Pinniger GJ
    PLoS One; 2019; 14(4):e0214908. PubMed ID: 30970035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies.
    Cárdenas AM; González-Jamett AM; Cea LA; Bevilacqua JA; Caviedes P
    Exp Neurol; 2016 Sep; 283(Pt A):246-54. PubMed ID: 27349407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid accumulation in dysferlin-deficient muscles.
    Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
    Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.
    Cea LA; Puebla C; Cisterna BA; Escamilla R; Vargas AA; Frank M; Martínez-Montero P; Prior C; Molano J; Esteban-Rodríguez I; Pascual I; Gallano P; Lorenzo G; Pian H; Barrio LC; Willecke K; Sáez JC
    Cell Mol Life Sci; 2016 Jul; 73(13):2583-99. PubMed ID: 26803842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null mice.
    Barzilai-Tutsch H; Dewulf M; Lamaze C; Butler Browne G; Pines M; Halevy O
    Hum Mol Genet; 2018 Aug; 27(16):2817-2829. PubMed ID: 29771357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysferlin Deficiency Results in Myofiber-Type Specific Differences in Abundances of Calcium-Handling and Glycogen Metabolism Proteins.
    Lloyd EM; Pinniger GJ; Grounds MD; Murphy RM
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
    Gushchina LV; Bhattacharya S; McElhanon KE; Choi JH; Manring H; Beck EX; Alloush J; Weisleder N
    Mol Ther; 2017 Oct; 25(10):2360-2371. PubMed ID: 28750735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine.
    Cea LA; Vásquez W; Hernández-Salinas R; Vielma AZ; Castillo-Ruiz M; Velarde V; Salgado M; Sáez JC
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diltiazem improves contractile properties of skeletal muscle in dysferlin-deficient BLAJ mice, but does not reduce contraction-induced muscle damage.
    Begam M; Collier AF; Mueller AL; Roche R; Galen SS; Roche JA
    Physiol Rep; 2018 Jun; 6(11):e13727. PubMed ID: 29890050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle Cells Fix Breaches by Orchestrating a Membrane Repair Ballet.
    Barthélémy F; Defour A; Lévy N; Krahn M; Bartoli M
    J Neuromuscul Dis; 2018; 5(1):21-28. PubMed ID: 29480214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice.
    Farini A; Tripodi L; Villa C; Napolitano F; Strati F; Molinaro D; Facciotti F; Cassani B; Torrente Y
    Cell Death Dis; 2022 Nov; 13(11):975. PubMed ID: 36402750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
    Vallecillo-Zúniga ML; Rathgeber MF; Poulson PD; Hayes S; Luddington JS; Gill HN; Teynor M; Kartchner BC; Valdoz J; Stowell C; Markham AR; Arthur C; Stowell S; Van Ry PM
    PLoS One; 2020; 15(9):e0238441. PubMed ID: 32881965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout mice.
    Yasa J; Reed CE; Bournazos AM; Evesson FJ; Pang I; Graham ME; Wark JR; Nijagal B; Kwan KH; Kwiatkowski T; Jung R; Weisleder N; Cooper ST; Lemckert FA
    Acta Neuropathol Commun; 2023 Jan; 11(1):15. PubMed ID: 36653852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.
    Sellers SL; Milad N; White Z; Pascoe C; Chan R; Payne GW; Seow C; Rossi F; Seidman MA; Bernatchez P
    J Lipid Res; 2018 Feb; 59(2):261-272. PubMed ID: 29175948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy.
    Potter RA; Griffin DA; Sondergaard PC; Johnson RW; Pozsgai ER; Heller KN; Peterson EL; Lehtimäki KK; Windish HP; Mittal PJ; Albrecht DE; Mendell JR; Rodino-Klapac LR
    Hum Gene Ther; 2018 Jul; 29(7):749-762. PubMed ID: 28707952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.